Skip to content
The Policy VaultThe Policy Vault

Eliquis (apixaban tablets)Cigna

Treatment or Prevention of Other Thromboembolic-Related Conditions

Initial criteria

  • Patient weight ≥ 35 kg
  • AND Patient meets ONE of the following:
  • Patient has tried warfarin, fondaparinux injection, or a low molecular weight heparin product (e.g., enoxaparin injection, Fragmin [dalteparin injection])
  • OR Patient has been started on Eliquis for the treatment of an acute thromboembolic condition

Approval duration

6 months